The Patent Finder

Terms ending in 2027

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 7,632,946Naphthyridine-Based Antibacterial Compositions
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 7,910,595Anti-Viral Compounds
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,586,746Amino-Aza-Adamantane Derivatives and Methods of Use
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,540,432Anti-Aß Globulomer 7C6 Antibodies
In force
 · Medium confidence
AbbVie Deutschland GmbH & Co. KGIn forceMedium confidence
US 7,642,260Apoptosis Promoters
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 7,956,185CYCLOBUT-3-ENE-1,2,-Dione Inhibitors of Polo-Like Kinases
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 7,662,958Anti-Infective Agents
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 7,951,800Anti-Infective Agents
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 7,973,161Apoptosis Promoters
In force
 · Medium confidence
AbbVie Inc.In forceMedium confidence
US 7,999,117Substituted 1H-BENZIMIDAZOLE-4-Carboxamides Are Potent Parp Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
21 more term ends in 2027 · Pro
10 of 31 patents shown. Soonest term end first, then patent number.
Pro members see all 31, all of them expiring within the 18 months from Nov 21, 2026.
Upgrade to Pro
30 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited